Guide
Regulatory intelligence software for medical device teams
Regulatory intelligence is the practice of gathering, interpreting, and acting on the rules, guidance, and precedents that decide whether and when a medical device can reach a market. Software makes that practice repeatable instead of ad hoc.
What regulatory intelligence software actually does
Most device teams start with spreadsheets, agency websites, consultant memos, and a shared drive. That works until you are tracking more than one device across more than one market, at which point the same question gets researched twice and the answers disagree.
Regulatory intelligence software centralises those sources, keeps a record of what was decided and why, and puts the current requirements for a device class and market in front of the people making launch decisions.
- Collects requirements, guidance, and classification rules per market in one place
- Compares pathways side by side rather than one market at a time
- Keeps an auditable record of the analysis behind a launch decision
- Shares one version of the regulatory picture with commercial and clinical teams
What to look for when evaluating a tool
The useful differences between tools are rarely in the feature list. They show up in how quickly a new question can be answered and how much of the answer you can defend to a reviewer or an executive.
- Coverage: which markets and device classes are supported, and how current the data is
- Traceability: can every conclusion be traced back to a source
- Comparison: can two or more markets be evaluated against the same criteria
- Output: does it produce something you can put in front of a board, not just a dashboard
- Fit with your workflow: whether regulatory, commercial, and clinical teams can all use it
How MedTech Compass approaches it
MedTech Compass combines MedTech regulatory triage with medical device market intelligence: it maps global FDA pathways — 510(k), De Novo, and PMA — against EU MDR and UKCA routes so a team can see the trade-off before committing resources to one. It applies multi-dimensional market scoring across 25+ markets with custom weights and payment forecasting, and exports executive-ready summaries that align regulatory and commercial strategy.
For the documentation side of the same programme, MedTech Copilot works as AI medical device documentation and MedTech QMS software, producing automated design history files and audit-ready records from the evidence a team already generates.
Teams usually begin with the free Market Signal tier to validate a single market question, then move to a single launch-ready report or an ongoing workflow once the approach proves out.
Frequently asked questions
- Is regulatory intelligence the same as regulatory affairs?
- No. Regulatory affairs owns submissions and interactions with agencies. Regulatory intelligence is the research and analysis layer that informs those decisions — which pathway, which market, and on what evidence.
- Do small device companies need dedicated software?
- Not always. A single device in a single market can be managed manually. The case for software appears when you evaluate several markets, revisit decisions as guidance changes, or need to show the reasoning behind a launch plan to investors or a board.
- Does software replace a regulatory consultant?
- No. It reduces the amount of billable time spent on research that a tool can do faster, so consultants focus on judgment calls and submission strategy.